Menu

Search

Jane Gifkins

Jane Gifkins

Researcher, Centre for Work, Organisation and Wellbeing, Griffith University
I have recently completed my Ph.D where I investigated the impact of shift work on health and well-being. My research focus is primarily fatigue and the optimal ways to recover both at work and during home time. My work background is a laboratory scientist bringing a unique perspective to my social science research.

Switching off from work has never been harder, or more necessary. Here's how to do it

Dec 26, 2023 23:04 pm UTC| Health

In the hit dystopian TV series Severance, employees at biotech corporation Lumon Industries find it easy to separate work and home life. A computer chip is inserted in their brains to act as a mindwipe. They leave all...

1 

Economy

Thailand’s Exports Surge to 3-Year High Despite U.S. Tariff Risks

Thailands exports jumped 17.8% year-on-year in March, marking the ninth consecutive monthly increase and the highest level in three years, according to the Commerce Ministry. The figure outperformed analysts expectations...

FxWirePro- Major Economic Events for the day

Time Currency Detail Actual Forecast Previous 2:30am AUD RBA...

Malaysia Weighs Growth Forecast Cut as U.S. Tariff Deadline Looms

Malaysia is likely to lower its 2025 GDP growth forecast of 4.5% to 5.5% due to rising trade tensions and looming U.S. tariffs, according to Bank Negara Malaysia Governor Abdul Rasheed Ghaffour. Speaking at an IMF event in...

Asian Stocks Edge Higher as Japan Gains, Korea Lags on Weak GDP

Asian stocks saw modest gains on Thursday, with Japan leading the region on renewed hopes of U.S. trade dialogue. Investors remained cautious, reassessing optimism over a potential de-escalation in the U.S.-China trade war...

U.S. Stock Futures Edge Higher on Trade Hopes, Alphabet Earnings in Focus

U.S. stock index futures inched higher Wednesday evening as optimism over easing U.S.-China trade tensions lifted sentiment. Investor focus also shifted toward key tech earnings, with Alphabet (NASDAQ: GOOGL) set to report...

Politics

Japan’s Economy Minister Heads to U.S. for Crucial Tariff Negotiations

Japans Economy Minister Ryosei Akazawa is set to travel to Washington from April 30 to May 2 for a second round of high-stakes negotiations with U.S. officials regarding tariffs on Japanese exports, according to media...

Trump Signs Executive Order Tightening College Accreditation and Targeting Foreign Funding

President Donald Trump signed a sweeping executive order on Wednesday aimed at tightening college accreditation standards, a move that could affect access to billions in federal student aid. The order is part of a broader...

Carney, Poilievre Clash in B.C. as Tight Election Nears

Canadian Prime Minister Mark Carney made a campaign push in British Columbia on Wednesday, targeting support in one of Canadas most competitive regions ahead of Mondays national election. With the Liberals leading in...

Global Vaccine Drive at Risk as US Cuts Aid, Warns UN

Funding cuts, particularly from the United States, are jeopardizing global childhood vaccination efforts at a scale comparable to the COVID-19 pandemics disruption, the United Nations warned. According to a joint statement...

Trump to Hold Michigan Rally Marking First 100 Days in Office

U.S. President Donald Trump will host a rally in Macomb County, Michigan, on Tuesday to celebrate his first 100 days in office, according to a White House announcement. The event marks Trumps return to a key battleground...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Nintendo Switch 2 Sees Surging Demand with 2.2 Million Lottery Applications in Japan

Nintendo has revealed that over 2.2 million people have entered a lottery for the new Switch 2 console in Japan, signaling overwhelming demand ahead of its June 5 launch. The company admitted it cannot fulfill all orders...

TSMC to Launch Advanced 1.4nm Chips by 2028 to Power AI Growth

Taiwan Semiconductor Manufacturing Company (TSMC), the worlds leading contract chipmaker and a key supplier to Nvidia (NASDAQ:NVDA), announced plans to begin mass production of its next-generation 1.4 nanometer (nm) chip...

SK Hynix Q1 Profit Soars on AI Chip Boom and Tariff Stockpiling

SK Hynix (KRX:000660) more than doubled its quarterly operating profit as demand for AI chips surged and clients stockpiled inventory ahead of potential U.S. tariffs. The worlds second-largest memory chipmaker posted an...

BMW to Integrate Chinese AI from DeepSeek in China-Made Vehicles

German automotive giant BMW (ETR:BMWG) announced it will begin integrating artificial intelligence (AI) developed by Chinese startup DeepSeek into its upcoming vehicle models in China starting later this year. The...

Tesla’s Optimus Robot Faces Delays Amid China’s Rare Earth Export Curbs

Tesla CEO Elon Musk revealed that production of the companys Optimus humanoid robot has been delayed due to Chinas new export restrictions on rare earth magnetscritical components in robotics and electric vehicles....
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.